EX-99.1 2 upxi_ex991.htm PRESS RELEASE upxi_ex991.htm

EXHIBIT 99.1

 

 

Upexi Reports Fiscal Second Quarter 2024 Financial Results

 

TAMPA, FL, February 14, 2024 (ACCESSWIRE) – Upexi, Inc. (NASDAQ: UPXI) (the “Company” or “Upexi”), a multi-faceted Amazon and Direct to Consumer brand owner and innovator in aggregation, today reported its financial results for the fiscal second quarter 2024 ending December 31, 2023.

 

“During the quarter we continued to focus on optimizing and streamlining our operations, investing in our higher margin Brand Products and generating positive Adjusted EBITDA. While revenue for the most recent fiscal second quarter decreased sequentially, the operating measures we took allowed us to increase gross profit margins to 38%, as compared to the prior fiscal first quarter of 31.8%. We also generated positive Adjusted EBITDA although revenue quarter-over-quarter was down. The revenue decrease sequentially was predominately related to the calculated decision to reduce risk of purchasing excess inventory in our re-commerce business. This business is carefully managed quarter-over-quarter based on opportunities that we determine are low risk and will yield us higher than normal margins for that business. We invested in our Brand Products, which increased revenue sequentially 16.7%.” Allan Marshall, CEO of Upexi continued, “We see further improvement to margins in the near term as we finalize the consolidation of our manufacturing facilities, which is expected to yield approximately $2 million in general and administrative expense reductions annually beginning at the end of April of this year. We remain committed to further expanding and enhancing our Brand Products and Re-commerce segments, capitalizing on new growth opportunities and delivering sustainable value.”

 

Fiscal Second Quarter 2024 Financial Highlights

 

·

Revenue was $21.8 million, compared to $26.7 million in fiscal Q2 2023 and $27.3 million in fiscal Q1 2024.

 

·

Branded Product revenue was $7.7 million, an increase of 16.7% as compared to $6.6 million in fiscal Q1 2024.

 

·

Branded Product revenue as a percentage of total revenue was 35.1% as compared to 24% in fiscal Q1 2024.

 

·

Cost of revenue was $13.6 million, compared to $16.7 million in fiscal Q2 2023 and $18.6 million in fiscal Q1 2024.

 

·

Gross Profit Margin was 38%, compared to 38% in fiscal Q2 2023 and 31.8% in fiscal Q1 2024.

 

·

GAAP Net loss attributable to Upexi, Inc. was $2.4 million, compared to net income of $2.7 million in fiscal Q2 2023 and net loss of $1.4 million in fiscal Q1 2024.

 

·

Adjusted EBITDA from continuing operations was $29,111 in fiscal Q2 2023, compared to $557,019 in fiscal Q2 2023 and $750,000 in fiscal Q1 2024.

 

·

Cash at December 31, 2023 was $1.8 million.

 

·

Total stockholders’ equity at December 31, 2023 was $25.5 million.

 

Fiscal Second Quarter 2024 and Subsequent Operational Highlights

 

·

Tytan Tiles Toy Brand launched its first licensed Disney Frozen Product on Amazon through its partnership with The Walt Disney Company.

 

·

In one month during the quarter, since Tytan Tiles launched its Disney Frozen Kit on Amazon on October 17, 2023, it rose to #1 for Amazon's New Releases in Preschool Building Sets, #3 top seller in Magnetic Building Sets, and broke into the top 400 in all Toys and Games on Amazon.

 

·

Subscription revenue across Health and Wellness grew approximately 5% per month.

 

·

Closed quarter with over 5,000 subscribers across Health and Wellness, up approximately 80% for 2023.

 

Financial Highlights for the Fiscal Second Quarter 2024 Ended December 31, 2023

Revenue for the fiscal second quarter 2024 totaled $21.8 million as compared to $26.7 million for the same period the prior year and $27.3 million for the fiscal first quarter 2024. The decrease in revenue was primarily due to lower re-commerce revenue through both Amazon channels and wholesale. During the quarter, there were certain wholesale transactions not completed as a decision from management that resulted in higher inventory and lower sales. Brand Product sales during the quarter increased 16.7% sequentially to $7.7 million as compared to $6.6 million led by the health and beauty product categories. Management will continue to focus on the development and growth of the high gross margin Brand Product sales.

 

Cost of revenue for the fiscal second quarter 2024 totaled $13.6 million, a decrease as compared to $16.7 million for the same period the prior year and $18.6 million for the fiscal first quarter 2024. The cost of revenue decrease was primarily related to a decrease in re-commerce sales discussed above.

 

 

 

 

Gross profit margin for the fiscal second quarter of 2024 and 2023 was approximately 38% during both periods. Gross profit margin during the quarter increased sequentially to 38% as compared to 31.8%.

 

Sales and marketing expenses for the fiscal second quarter 2024 decreased 18% compared with the same period in the prior year. The decrease in sales and marketing expenses was primarily related to Management’s efforts to refine sales strategies to focus on long-term recurring sales growth through subscription revenue and sales channel expansion. Management will continue to manage its sales and marketing budget strategically for direct-to-consumer sales channels as the Company capitalizes on an opportunity to take advantage of lower costs to estimated lifetime value of the customer. Management believes that this strategy will yield significant returns in the next 12 months. Management anticipates its advertising expenses will be reduced over time as a percentage of sales in the following quarters, which will increase overall profitability.

 

General and administrative expenses for the fiscal second quarter 2024 totaled $2.3 million, a decrease of 9%, as compared to $2.5 million for the same period the prior year. Management has managed its general and administrative costs and will continue to implement strategies to decrease the percentage of general and administrative costs when compared to total sales.

 

Adjusted EBITDA was approximately $29 thousand as compared to an Adjusted EBITDA of approximately $557 thousand for the same period the prior year and $750 thousand for the fiscal first quarter 2024.

 

The Company had a net loss from continued operations for the fiscal second quarter 2024 of $2.4 million as compared to net income of $2.7 million for the same period the prior year and a net loss of $1.4 million in the fiscal first quarter 2024.

As of December 31, 2023, the Company had cash of $1.8 million and total stockholders’ equity attributed to Upexi stockholders of approximately $25.5 million.

 

As of February 14, 2024, there are 20,889,384 shares of common stock outstanding.

 

Financial Results Conference Call

Event:

Fiscal Second Quarter 2024 Financial Results Conference Call

 

 

Date:

Wednesday, February 14, 2024

 

 

Time:

4:30 p.m. Eastern Time

 

 

Live Call:

1-877-407-9716 (U.S. Toll-Free) or 1-201-493-6779 (International)

 

 

Webcast:

https://ir.upexi.com/news-events/ir-calendar

 

For those unable to join the conference call, a dial-in replay of the call will be available until February 28, 2024 and can be accessed by dialing + 1-844-512-2921 (U.S. Toll Free) or + 1-412-317-6671 (International) and entering replay pin number: 13744405. Additional details are available under the Investor Relations section of the Company's website: https://upexi.com/investors.

 

About Upexi, Inc.:

Upexi is a multi-faceted brand owner with established brands in the health, wellness, pet, beauty and other growing markets. We operate in emerging industries with high growth trends and look to drive organic growth of our current brands. We focus on direct to consumer and Amazon brands that are scalable and have anticipated, high industry growth trends. Our goal is to continue to accumulate consumer data and build out a significant customer database across all industries we sell into. The growth of our current database has been key to the year over year gains in sales and profits. To drive additional growth, we have and will continue to acquire profitable Amazon and eCommerce businesses that can scale quickly and reduce costs through corporate synergies. We utilize our in-house, SaaS programmatic ad technology to help achieve a lower cost per acquisition and accumulate consumer data for increased cross-selling between our growing portfolio of brands.

 

 
2

 

 

FORWARD LOOKING STATEMENTS:

This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with business strategy, potential acquisitions, revenue guidance, product development, integration and synergies of acquiring companies and personnel. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

 

Adjusted EBITDA

 

 

 

 

 

 

 

 

Three Months Ended

 

 

 

30-Sep-23

 

 

31-Dec-23

 

Net income (Net loss) GAAP

 

 

(1,356,388 )

 

 

(2,437,919 )

Interest expense, net

 

 

874,185

 

 

 

1,077,084

 

Depreciation and amortization

 

 

1,472,905

 

 

 

1,485,648

 

Income Tax

 

 

(472,367 )

 

 

(694,807 )

Stock Compensation

 

 

421,887

 

 

 

330,584

 

Gain on sale of asset

 

 

(380,624 )

 

 

39,691

 

Change in derivative liability

 

 

-

 

 

 

-

 

Lease Impairment

 

 

-

 

 

 

228,830

 

Loss from discontinued operations

 

 

193,040

 

 

 

-

 

Loss attributable to non-controlling interest

 

 

-

 

 

 

-

 

 

 

$ 752,638

 

 

$ 29,111

 

 

Adjusted EBITDA

 

 

 

Three Months Ended

 

 

 

30-Sep-22

 

 

31-Dec-22

 

 Net income (Net loss) GAAP

 

$ (2,597,515 )

 

$ 2,669,679

 

 Interest expense, net

 

 

161,970

 

 

 

1,789,299

 

 Depreciation and amortization

 

 

1,063,492

 

 

 

1,204,628

 

 Income Tax

 

 

(708,201 )

 

 

755,253

 

 Stock Compensation

 

 

927,326

 

 

 

1,052,847

 

 Gain on sale of asset

 

 

-

 

 

 

(7,564,363 )

 Change in derivative liability

 

 

(1,770 )

 

 

3,540

 

 Loss from discontinued operations

 

 

644,615

 

 

 

731,717

 

 Loss attributable to non-controlling interest

 

 

(148,005 )

 

 

(85,581 )

 

 

$ (1,409,397 )

 

$ 557,019

 

 

Use of Non-GAAP Financial Measures

The Company discloses and uses the above-mentioned non-GAAP financial measures internally as a supplement to GAAP financial information to evaluate its operating performance, for financial planning purposes, to establish operational goals, for compensation plans, to measure debt service capability, for capital expenditure planning and to determine working capital needs and believes that these are useful financial measures also used by investors. Non-GAAP adjusted EBITDA is defined as GAAP net income or net loss before interest, taxes, depreciation and amortization (EBITDA) adjusted for the non-cash stock compensation and stock option expense, acquisition, integration & restructuring expenses, charges and gains or losses from extinguishment of debt and other non-cash items. Non-GAAP EBITDA and non-GAAP adjusted EBITDA are not terms defined by GAAP and, as a result, the Company's measure of non-GAAP EBITDA and non-GAAP adjusted EBITDA might not be comparable to similarly titled measures used by other companies. Generally, a non-GAAP financial measure is a numerical measure of a company's performance, financial position, or cash flow that either excludes or includes amounts that are not normally included in the most directly comparable measure calculated and presented in accordance with GAAP. The non-GAAP financial measures discussed above, however, should be considered in addition to, and not as a substitute for, or superior to net income or net loss as reported for GAAP on the Consolidated Statements of Operations, cash and cash flows on the Consolidated Statement of Cash Flows or other measures of financial performance prepared in accordance with GAAP, and as reflected on the Company's financial statements prepared in accordance with GAAP. These non-GAAP financial measures are not a substitute for or presented in lieu of financial measures provided by GAAP and all measures and disclosures of financial information pursuant to GAAP should be read to obtain a comprehensive and thorough understanding of the Company's financial results. The reconciliations of non-GAAP EBITDA and non-GAAP adjusted EBITDA to GAAP operating income (loss) and/or GAAP net income (net loss) referred to in the highlights or elsewhere are provided in the schedules that are a part of this document.

 

Company Contact

Andrew Norstrud, Chief Financial Officer

Email: andrew.norstrud@upexi.com

Phone: (702) 332-5591

 

Investor Relations Contact

KCSA Strategic Communications

Valter Pinto

Email: Upexi@KCSA.com

Phone: (212) 896-1254

 

 
3

 

 

UPEXI, INC.

 

 

 

 

 

 

CONDENSED CONSOLDIATED BALANCE SHEETS (UNAUDITED)

 

 

 

 

 

 

 

 

 

 

 

 

December 31,

 

 

June 30,

 

 

 

2023

 

 

2023

 

 

 

 

 

 

 

 

ASSETS

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

Cash

 

$ 1,844,420

 

 

$ 4,492,291

 

Accounts receivable

 

 

5,377,244

 

 

 

7,163,564

 

Inventory

 

 

14,663,908

 

 

 

11,557,128

 

Due from Bloomios

 

 

-

 

 

 

845,443

 

Prepaid expenses and other receivables

 

 

697,559

 

 

 

1,307,299

 

Current assets of discontinued operations

 

 

-

 

 

 

89,989

 

Total current assets

 

 

22,583,131

 

 

 

25,455,714

 

 

 

 

 

 

 

 

 

 

Property and equipment, net

 

 

7,600,398

 

 

 

7,526,463

 

Intangible assets, net

 

 

11,298,110

 

 

 

13,571,960

 

Goodwill

 

 

11,808,571

 

 

 

10,251,281

 

Deferred tax asset

 

 

6,771,230

 

 

 

5,604,056

 

Other assets

 

 

441,844

 

 

 

96,728

 

Assets held for sale

 

 

-

 

 

 

936,054

 

Right-of-use asset

 

 

1,657,463

 

 

 

410,811

 

Total other assets

 

 

39,577,616

 

 

 

38,397,353

 

 

 

 

 

 

 

 

 

 

Total assets

 

$ 62,160,747

 

 

$ 63,853,067

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS' EQUITY

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

 

Accounts payable

 

$ 3,017,764

 

 

$ 3,969,746

 

Accrued compensation

 

 

495,228

 

 

 

533,842

 

Deferred revenue

 

 

104,149

 

 

 

-

 

Accrued liabilities

 

 

2,658,347

 

 

 

3,365,562

 

Acquisition payable

 

 

300,000

 

 

 

-

 

Current portion of notes payable

 

 

4,206,474

 

 

 

1,302,021

 

Current portion of convertible notes payable

 

 

-

 

 

 

1,254,167

 

Current portion of acquisition note payable

 

 

8,483,028

 

 

 

5,656,620

 

Current portion of related party note payable

 

 

-

 

 

 

1,429,356

 

Line of Credit

 

 

4,167,377

 

 

 

882,845

 

Current portion of operating lease payable

 

 

823,702

 

 

 

419,443

 

Current liabilities of discontinued operations

 

 

-

 

 

 

792,408

 

Total current liabilities

 

 

24,256,069

 

 

 

19,606,010

 

 

 

 

 

 

 

 

 

 

Operating lease payable, net of current portion

 

 

1,162,687

 

 

 

163,359

 

Related party note payable

 

 

1,459,630

 

 

 

-

 

Convertible notes payable

 

 

2,150,000

 

 

 

895,833

 

Acquisition notes payable, net of current

 

 

3,199,683

 

 

 

7,605,085

 

Notes payable, net of current portion

 

 

4,470,017

 

 

 

7,746,157

 

Total long-term liabilities

 

 

12,442,017

 

 

 

16,410,434

 

 

 

 

 

 

 

 

 

 

Commitments and contingencies

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stockholders' equity

 

 

 

 

 

 

 

 

Preferred stock, $0.001 par value, 100,000,000 shares authorized, and 500,000 and 500,000 shares issued and outstanding, respectively

 

 

500

 

 

 

500

 

Common stock, $0.001 par value, 100,000,000 shares authorized, and 20,397,779 and 16,713,345 shares issued and outstanding, respectively

 

 

20,307

 

 

 

20,216

 

Additional paid in capital

 

 

52,437,336

 

 

 

51,522,229

 

Accumulated deficit

 

 

(26,995,482 )

 

 

(23,201,175 )

Total stockholders' equity attributable to Upexi, Inc.

 

 

25,462,661

 

 

 

28,341,770

 

Non-controlling interest in subsidiary

 

 

 

 

 

 

(505,147 )

Total stockholders' equity

 

 

25,462,661

 

 

 

27,836,623

 

 

 

 

 

 

 

 

 

 

Total liabilities and stockholders' equity

 

$ 62,160,747

 

 

$ 63,853,067

 

 

 
4

 

 

UPEXI, INC.

 

 

 

 

 

 

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

 

 

 

 

 

 

 

 

 

Three Month's Ended December 31,

 

 

 

2023

 

 

2022

 

 

 

 

 

 

 

 

Revenue

 

 

 

 

 

 

Revenue

 

$ 21,827,827

 

 

$ 26,741,562

 

 

 

 

 

 

 

 

 

 

Cost of Revenue

 

 

13,556,574

 

 

 

16,655,117

 

 

 

 

 

 

 

 

 

 

Gross profit

 

 

8,271,253

 

 

 

10,086,445

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

 

Sales and marketing

 

 

2,691,368

 

 

 

3,297,144

 

Distribution costs

 

 

3,247,554

 

 

 

3,575,545

 

General and administrative expenses

 

 

2,303,220

 

 

 

2,517,651

 

Share-based compensation

 

 

330,584

 

 

 

1,052,847

 

Amortization of acquired intangible assets

 

 

1,157,029

 

 

 

1,102,756

 

Depreciation

 

 

328,619

 

 

 

240,958

 

 

 

 

10,058,374

 

 

 

11,786,901

 

 

 

 

 

 

 

 

 

 

Loss from operations

 

 

(1,787,121 )

 

 

(1,700,456 )

 

 

 

 

 

 

 

 

 

Other income (expense), net

 

 

 

 

 

 

 

 

Change in derivative liability

 

 

-

 

 

 

(3,540 )

Interest (expense) income, net

 

 

(1,077,084 )

 

 

(1,789,299 )

 

 

 

 

 

 

 

 

 

Other income (expense), net

 

 

(1,077,084 )

 

 

(1,792,839 )

 

 

 

 

 

 

 

 

 

Income (loss) on operations before income tax

 

 

(2,864,205 )

 

 

(3,493,295 )

Gain on sale of Infusionz and select assets

 

 

-

 

 

 

7,564,363

 

Gain (loss) from the sale of Interactive Offers

 

 

(39,691 )

 

 

-

 

Lease settlement, California facility

 

 

61,138

 

 

 

-

 

Lease impairment, Delray Beach facility

 

 

(289,968 )

 

 

-

 

(Loss) income from discontinued operations

 

 

-

 

 

 

 

 

Income tax benefit (expense)

 

 

694,807

 

 

 

(755,253 )

 

 

 

 

 

 

 

 

 

Net income (loss) from continuing operations

 

 

(2,437,919 )

 

 

3,315,815

 

 

 

 

 

 

 

 

 

 

(Loss) income from discontinued operations

 

 

-

 

 

 

(731,717 )

 

 

 

 

 

 

 

 

 

Net loss attributable to non-controlling interest

 

 

-

 

 

 

85,581

 

 

 

 

 

 

 

 

 

 

Net income (loss) attributable to Upexi, Inc.

 

$ (2,437,919 )

 

$ 2,669,679

 

 

 

 

 

 

 

 

 

 

Basic income (loss) per share:

 

 

 

 

 

 

 

 

Income (loss) per share from continuing operations

 

$ (0.12 )

 

$ 0.15

 

(Loss) income per share from discontinued operations

 

$ -

 

 

$ (0.04 )

Total income (loss) per share

 

$ (0.12 )

 

$ 0.15

 

 

 

 

 

 

 

 

 

 

Diluted income (loss) per share:

 

 

 

 

 

 

 

 

Income (loss) per share from continuing operations

 

$ (0.12 )

 

$ 0.17

 

(Loss) income per share from discontinued operations

 

$ -

 

 

$ -

 

Total income (loss) per share

 

$ (0.12 )

 

$ 0.17

 

 

 

 

 

 

 

 

 

 

Basic weighted average shares outstanding

 

 

20,306,871

 

 

 

17,540,427

 

Fully diluted weighted average shares outstanding

 

 

20,306,871

 

 

 

19,030,705

 

 

 
5